The long and winding road towards induction of allograft tolerance in the clinic

Transplant International

Volumn 21, Issue 8, 2008, Pages 725-727

  Chatenoud, Lucienne ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CADAVER DONOR; CELL THERAPY; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY GRAFT; LIVING DONOR; MIXED LYMPHOCYTE CULTURE; MONOCYTE; NONHUMAN; NOTE; PRIORITY JOURNAL; SURVIVAL RATE; IMMUNOLOGY; MACROPHAGE; TRANSPLANTATION TOLERANCE;

HUMANS; IMMUNOSUPPRESSION; MACROPHAGES; MONOCYTES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION TOLERANCE;

EID: 57649084666     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00713.x     Document Type: Note

References (14)

1. Hutchinson JA, Riquelme P, Brem-Exner BG, et al. Transplant acceptance-inducing cells as an immune-conditioning therapy in renal transplantation. Transplant Int: 10.1111/j.1432-2277.2008.00680.x [E-pub ahead of print].
2. Hutchinson JA, Brem-Exner BG, Riquelme P, et al. A cell-based approach to the minimization of immuno-suppression in renal transplantation. Transpl Int: 10.1111/j.1432-2277.2008.00692.x [E-pub ahead of print].
3. Fandrich F, Zhou X, Schlemminger M, Lin X, Dresske B. Future strategies for tolerance induction: a comparative study between hematopoietic stem cells and macrophages. Hum Immunol 2002; 63: 805.
4. Fandrich F, Dresske B, Bader M, Schulze M. Embryonic stem cells share immune-privileged features relevant for tolerance induction. J Mol Med 2002; 80: 343.
5. Fandrich F, Lin X, Chai GX, et al. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 2002; 8: 171.
6. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosup-pression. N Engl J Med 2008; 358: 353.
7. Wood ML, Monaco AP, Gozzo JJ, Liegeois A. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing. Transplant Proc 1971; 3: 676.
8. Shizuru JA, Seydel KB, Flavin TF, et al. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Transplantation 1990; 50: 366.
9. Maki T, Gottschalk R, Wood ML, Monaco AP. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells. J Immunol 1981; 127: 1433.
10. Qin S, Cobbold SP, Pope H, et al. "Infectious" transplantation tolerance. Science 1993; 259: 974.
11. Darby CR, Morris PJ, Wood KJ. Evidence that long-term cardiac allograft survival induced by anti-CD4 monoclonal antibody does not require depletion of CD4+ T cells. Transplantation 1992; 54: 483.
12. Wekerle T, Kurtz J, Bigenzahn S, Takeuchi Y, Sykes M. Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 2002; 14: 592.
13. Cosimi AB, Delmonico FL, Wright JK, et al. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery 1990; 108: 406.
14. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439.